Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms
Margaret Nieborowska-Skorska(Temple University), Tomasz Skórski(Temple University)
Cited by 77
Related Papers
BCR/ABL and Other Kinases from Chronic Myeloproliferative Disorders Stimulate Single-Strand Annealing, an Unfaithful DNA Double-Strand Break Repair
|Cancer Research|2008|95
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells
|Journal of Clinical Investigation|2017|75